Skip to main content
Top
Published in: Annals of Nuclear Medicine 4/2010

01-05-2010 | Original Article

Evaluation of the risk of radiation exposure from new 18FDG PET/CT plans versus conventional X-ray plans in patients with pediatric cancers

Authors: Takeshi Murano, Ukihide Tateishi, Takeshi Iinuma, Naoki Shimada, Hiromitsu Daisaki, Takashi Terauchi, Noriyuki Moriyama, Tomio Inoue

Published in: Annals of Nuclear Medicine | Issue 4/2010

Login to get access

Abstract

Objective

Unnecessary radiological examination should be avoided, particularly for children, who are more vulnerable to radiation than adults. Replacement of X-ray examination with 18F-fluoro-2-deoxy-d-glucose (18FDG) positron emission tomography/computed tomography (PET/CT) is a potential option for reduction of radiation exposure, and thus improvement in the quality of life (QOL) of patients. Therefore, this study aimed to evaluate new plans integrating 18FDG PET/CT versus current conventional imaging (CI) plans for patients with pediatric cancers. The effects of radiation exposure from the two kinds of plans were compared using shortening of the average life expectancy as an index, and the related findings and effects of radiation exposure are discussed.

Methods

Effective radiation doses from CT scanning were calculated using the ImPACT CT Patient Dosimetry Calculator software. Radiation doses in different organs and tissues from radiopharmaceuticals were obtained from the International Commission on Radiological Protection (ICRP) publication 80. Shortening of average life expectancy was calculated using software in which the linear non-threshold model (LNT) by the ICRP was adopted.

Results

In current CI plans, the mean effective dose was 168.8 mSv (range 50.5–513.4 mSv) for males and 127 mSv (range 54–239.7 mSv) for females. The mean shortening of average life expectancy was 177 days (range 53.3–542 days) for males and 185 days (range 80.4–371 days) for females. In new plans, the mean effective dose was 64.1 mSv (range 54.1–84.5 mSv) for males and 68.2 mSv (range 58.1–88.0 mSv) for females. The mean shortening of life expectancy was 67.6 days (range 57.1–89.2 days) for males and 102.5 days (range 86.8–132.6 days) for females.

Conclusions

New 18FDG PET/CT plans may relieve the patient’s physical burden and contribute to improvement of the patient’s QOL. These plans may also reduce medical costs because the number of examinations to be performed is reduced. Although deterministic effects are not observed in the CI plan, careful attention should be paid to other potential effects. Because the effective dose resulting from this plan is over 100 mSv, at which stochastic effects are known to occur, radiation-induced cancers may be expected.
Literature
1.
go back to reference Berrington de Gonzalez A, Darby S. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet. 2004;363(9406):345–51. Berrington de Gonzalez A, Darby S. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet. 2004;363(9406):345–51.
2.
go back to reference Sodickson A, Baeyens PF, Andriole KP, Prevedello LM, Nawfel RD, Hanson R, et al. Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology. 2009;251(1):175–184. Sodickson A, Baeyens PF, Andriole KP, Prevedello LM, Nawfel RD, Hanson R, et al. Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology. 2009;251(1):175–184.
4.
go back to reference Murano T, Iinuma T, Tateno Y, Daisaki H, Tateishi U, Terauchi T, et al. Risk-benefit analysis of 18FDG PET cancer screening. Nippon Hoshasen Gijutsu Gakkai Zasshi. 2008;64(9):1151–6.PubMed Murano T, Iinuma T, Tateno Y, Daisaki H, Tateishi U, Terauchi T, et al. Risk-benefit analysis of 18FDG PET cancer screening. Nippon Hoshasen Gijutsu Gakkai Zasshi. 2008;64(9):1151–6.PubMed
5.
go back to reference Tateishi U, Hosono A, Makimoto A, Sakurada A, Terauchi T, Arai Y, et al. Accuracy of 18F fluorodeoxyglucose positron emission tomography/computed tomography in staging of pediatric sarcomas. J Pediatr Hematol Oncol. 2007;29(9):608–12.CrossRefPubMed Tateishi U, Hosono A, Makimoto A, Sakurada A, Terauchi T, Arai Y, et al. Accuracy of 18F fluorodeoxyglucose positron emission tomography/computed tomography in staging of pediatric sarcomas. J Pediatr Hematol Oncol. 2007;29(9):608–12.CrossRefPubMed
6.
go back to reference Volker T, Denecke T, Steffen I, Misch D, Schonoberger S, Plotkin M, et al. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol. 2007;25(34):5435–41.CrossRefPubMed Volker T, Denecke T, Steffen I, Misch D, Schonoberger S, Plotkin M, et al. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol. 2007;25(34):5435–41.CrossRefPubMed
7.
go back to reference Pirotte B, Acerbi F, Lubansu A, Goldman S, Brotchi J, Levivier M, et al. PET imaging in the surgical management of pediatric brain tumors. Childs Nerv Syst. 2007;23(7):739–751. doi:10.1007/s00381-077-0307-8. Pirotte B, Acerbi F, Lubansu A, Goldman S, Brotchi J, Levivier M, et al. PET imaging in the surgical management of pediatric brain tumors. Childs Nerv Syst. 2007;23(7):739–751. doi:10.​1007/​s00381-077-0307-8.
8.
go back to reference Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, et al. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Pediatr Blood Cancer. 2007;49(7):901–5.CrossRefPubMed Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, et al. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Pediatr Blood Cancer. 2007;49(7):901–5.CrossRefPubMed
9.
go back to reference Jones D, Shrimpton P. NRPB-SR250: Normalised organ doses for X-ray computed tomography calculated using monte carlo techniques. National Radiological Protection Board. 1993. Jones D, Shrimpton P. NRPB-SR250: Normalised organ doses for X-ray computed tomography calculated using monte carlo techniques. National Radiological Protection Board. 1993.
11.
go back to reference ICRP. Radiation dose to patients from radiopharmaceuticals: addendum 2 to ICRP publication 53: also includes addendum 1 to ICRP publication 72. ICRP Publication 80. Annals of the ICRP 29(3). Oxford: Elsevier Science Ltd; 1998. ICRP. Radiation dose to patients from radiopharmaceuticals: addendum 2 to ICRP publication 53: also includes addendum 1 to ICRP publication 72. ICRP Publication 80. Annals of the ICRP 29(3). Oxford: Elsevier Science Ltd; 1998.
12.
go back to reference ICRP. 1990 recommendations of the international commission on radiological protection. ICRP PUBLICATION 60. Annals of the ICRP 21 (1-3), Oxford: Elsevier Science Ltd; 1991. ICRP. 1990 recommendations of the international commission on radiological protection. ICRP PUBLICATION 60. Annals of the ICRP 21 (1-3), Oxford: Elsevier Science Ltd; 1991.
13.
go back to reference The 20th life table for japan 2005. Statistics and Information Department Minister’s Secretariat Ministry of Health; 2007. The 20th life table for japan 2005. Statistics and Information Department Minister’s Secretariat Ministry of Health; 2007.
14.
go back to reference Cancer Statistics in Japan 2007. The Editorial of the Cancer Statistics in Japan, 2007. Cancer Statistics in Japan 2007. The Editorial of the Cancer Statistics in Japan, 2007.
15.
go back to reference Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, Part 1. Cancer. 1950–1990. Radiat Res. 1996;146(1):1–27.CrossRefPubMed Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, Part 1. Cancer. 1950–1990. Radiat Res. 1996;146(1):1–27.CrossRefPubMed
Metadata
Title
Evaluation of the risk of radiation exposure from new 18FDG PET/CT plans versus conventional X-ray plans in patients with pediatric cancers
Authors
Takeshi Murano
Ukihide Tateishi
Takeshi Iinuma
Naoki Shimada
Hiromitsu Daisaki
Takashi Terauchi
Noriyuki Moriyama
Tomio Inoue
Publication date
01-05-2010
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 4/2010
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-010-0342-5

Other articles of this Issue 4/2010

Annals of Nuclear Medicine 4/2010 Go to the issue